Getinge stock
Price history
+33.98% over the period1 year: from kr 206.60 (November 20, 2025) to kr 276.80 (November 20, 2026), +33.98%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | kr 276.80 |
| October 30, 2026 | kr 277.70 |
| September 30, 2026 | kr 248.00 |
| August 31, 2026 | kr 243.90 |
| July 31, 2026 | kr 237.40 |
| June 30, 2026 | kr 198.10 |
| May 29, 2026 | kr 189.85 |
| April 30, 2026 | kr 183.55 |
| March 31, 2026 | kr 188.55 |
| February 27, 2026 | kr 202.90 |
| January 30, 2026 | kr 195.40 |
| December 30, 2025 | kr 218.80 |
| November 28, 2025 | kr 214.90 |
| November 20, 2025 | kr 206.60 |
At a glance
The company
Provides medical equipment and sterilization solutions for operating rooms, intensive care units and surgical workflows globally
Latest results
Quarter to September 30, 2026 · EPS kr 3.10 (estimate kr 2.51)
TickerLandia's take on Getinge
- Pricier than usual relative to earnings: P/E on the latest fiscal year 33 vs a median of 27 over its last 9 fiscal years.
- Priced in line with similar companies: trailing 12-month P/E 27 vs 30 (−10%) in a group of 10.
- Strong point: Market momentum (89/100 in its group). Weak point: Profitability (30/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−2.47% from the 52-week high
Analysts · 11 analysts
Average targetkr 272.91−1.41% vs. price
Buy 4 · Hold 6 · Sell 1
TickerLandia Fingerprint: Getinge
Compared with similar companies: very strong momentum.
Financials and price compared with 31 companies in the medical devices industry, worldwide. Momentum and risk compared with 1,160 European stocks.
Pricelow38
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 26.6 43 EV/EBITDA 13.8 32 Forward P/E 25.3 72 Price/sales 2.19 27 Price/book 2.31 15 Profitabilitylow30
How much it earns on revenue and capital.
Metric Value Position in group ROA 5.3% 40 Operating margin 14.3% 37 Gross margin 49.0% 27 Net margin 8.2% 21 ROE 9.1% 24 Earnings stabilityaverage53
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 2.8% 50 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 56 Growthaverage47
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +7.32% 56 Revenue growth (year over year) +2.70% 24 Earnings growth (year over year) +27.00% 60 Financial strengthlow34
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength 1.32 38 Debt/equitycounts in reverse: lower means more financial strength 0.34 60 Interest coverage 7.68 22 Current ratio 1.25 15 Dividendaverage58
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years at least 27 years 76 Dividend yield 1.7% 55 Payout ratio 45.7% 43 Market momentumvery strong89
How the stock has moved compared with the market.
Metric Value Position in group 1-year return +33.98% 81 Distance from 200-day average +25.62% 96 Risklow24
How much the price swings.
Metric Value Position in group Volatility (60 days) 18.1% 12 Maximum drawdown (12 months) 20.7% 36
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Getinge is pricier than in the past and cheaper than similar companies
On the latest fiscal year's earnings (2025), Getinge's P/E today is 33.4, above the median of its last 9 fiscal years (27.2; between 16.2 and 38.8 from 2016 to 2025). Getinge's P/E (trailing 12 months): 26.6, −10% against the median of a group of 10 similar companies (29.5).
Compared with 10 similar companies
| Metric | Getinge | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 26.6 | Low | |
| Forward P/E | 25.3 | Middle | |
| Operating margin | 14.3% | Middle | |
| ROE | 9.1% | Middle | |
| Debt/equity | 0.34 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Getinge. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
kr 8.45B
Latest quarter · Q3 2026
Net income
kr 719M
Latest quarter · Q3 2026
Quarterly net margin
8.5%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- kr 75.39B
- P/E
- 26.6
- EPS
- kr 10.39
- Volume
- 337.13K
- Daily trading
- €11.12M
- Dividend yield
- 1.72%
- Last ex-dividend on April 22, 2026
How Getinge is changing
All resultsRevenue grew 3.2% a year on average over the last 5 years
Profits turn into cash: free cash flow equal to 145% of net income
Revenue has grown for 4 fiscal years in a row
Returns
Getinge returns with dividends
kr 1,000 invested in Getinge 5 years ago, on November 22, 2021, would be worth kr 753 today with dividends reinvested: −24.75% in total, −5.53% per year. On price alone it would be kr 682 (−31.76%).
| Period | Getinge | kr 1,000 becomes |
|---|---|---|
| 1 month | +6.58% | kr 1,066 |
| 6 months | +40.54% | kr 1,405 |
| Year to date | +26.51% | kr 1,265 |
| 1 year | +37.23% | kr 1,372 |
| 3 years | +34.37% | kr 1,344 |
| 5 years | −24.75% | kr 753 |
| 10 years | +220.52% | kr 3,205 |
From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment
The chart in detail
Getinge: technical analysis
Getinge is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 35.5% below its all-time closing high (kr 429.40, November 15, 2021).
- Trend
- Upward
- RSI (14 sessions)
- 57
- Between 30 and 70
- vs 200-session average
- +25.62%
Support and resistance
Price areas where Getinge has stopped several times in the last year. They describe the chart; they are not forecasts.
- No resistance above: the price is near the highs of the year
- Last pricekr 276.80
- Supportkr 247.60−10.55%3 touches, last on September 7, 2026
- Supportkr 242.85−12.27%2 touches, last on October 6, 2026
- Supportkr 235.20−15.03%3 touches, last on September 11, 2026
Volatility and risk
- Volatility (60 sessions, annualised)
- 18.1%
- Largest fall in the last year
- −20.72%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Getinge: seasonality
Average monthly price change over 27 years
Over the last 27 years, the strongest month for Getinge has been July: +4.59% on average, positive in 18 years out of 27. The weakest has been June: −1.45% on average, positive in 11 years out of 27. November, the current month, has been positive in 17 years out of 26 (+2.26% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +4.19% | +5.00% | 15 of 26 |
| February | +1.44% | +1.38% | 14 of 27 |
| March | +0.22% | +0.71% | 14 of 27 |
| April | +1.39% | −0.65% | 13 of 27 |
| May | +0.10% | +1.43% | 15 of 27 |
| June | −1.45% | −1.39% | 11 of 27 |
| July | +4.59% | +3.81% | 18 of 27 |
| August | +0.06% | −1.19% | 13 of 27 |
| September | −1.19% | +0.46% | 14 of 27 |
| October | +2.07% | +6.94% | 16 of 27 |
| November | +2.26% | +2.74% | 17 of 26 |
| December | +1.63% | +2.19% | 17 of 26 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Getinge and its competitors
Sales reach customers in the Americas, Europe, the Middle East, Africa, and Asia and Pacific, through a network of the company's own sales companies as well as through agents and distributors. The product range covers extracorporeal membrane oxygenation, mechanical ventilation, patient monitoring and drainage systems, along with cardiac and vascular surgery equipment, peripheral stenting, and anesthesia and operating room integration.
- Headquarters
- Gothenburg, Sweden
- Employees
- 11,847
- Founded
- 1904
- Chief executive
- Mattias Perjos
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| GetingeGETI.B | $7.39B | 14.3% | 26.6 | +40.54% |
| SectraSECT.B | $6.24B | 20.6% | 105.8 | +21.58% |
| DemantDEMANT | $10.7B | 17.2% | 30.1 | +44.56% |
| Smith & NephewSN. | $12.57B | 14.2% | 20.8 | 0.00% |
| AmbuAMBU.B | $3.4B | 13.2% | 36.7 | +32.33% |
| Sonova HoldingSOON | $20.67B | 20.6% | 28.9 | +43.74% |
Same industry or related industries, similar size. Compare Getinge with its competitors · Full profile
